AmerisourceBergen Corp. (ABC) Shares Bought by BlueCrest Capital Management Ltd

BlueCrest Capital Management Ltd grew its stake in AmerisourceBergen Corp. (NYSE:ABC) by 50.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 10,886 shares of the company’s stock after purchasing an additional 3,650 shares during the quarter. BlueCrest Capital Management Ltd’s holdings in AmerisourceBergen were worth $1,000,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ABC. JPMorgan Chase & Co. grew its position in shares of AmerisourceBergen by 107.3% in the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock valued at $434,385,000 after purchasing an additional 2,776,287 shares during the period. Harding Loevner LP boosted its position in AmerisourceBergen by 89.6% during the third quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock worth $134,939,000 after acquiring an additional 1,496,761 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in AmerisourceBergen during the third quarter worth about $75,681,000. BlackRock Inc. boosted its position in AmerisourceBergen by 5.8% during the fourth quarter. BlackRock Inc. now owns 12,384,803 shares of the company’s stock worth $1,137,171,000 after acquiring an additional 679,417 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its position in AmerisourceBergen by 23.8% during the fourth quarter. Bank of New York Mellon Corp now owns 2,864,488 shares of the company’s stock worth $263,016,000 after acquiring an additional 550,215 shares during the last quarter. Institutional investors and hedge funds own 67.33% of the company’s stock.

How to Become a New Pot Stock Millionaire

ABC has been the topic of a number of recent research reports. Needham & Company LLC boosted their price target on shares of AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a research report on Wednesday, November 22nd. Robert W. Baird set a $99.00 price target on shares of AmerisourceBergen and gave the stock a “buy” rating in a research report on Friday, December 1st. Deutsche Bank initiated coverage on shares of AmerisourceBergen in a research report on Monday, December 4th. They set a “buy” rating and a $97.00 price target on the stock. Cowen set a $107.00 price target on shares of AmerisourceBergen and gave the stock a “buy” rating in a research report on Tuesday, December 12th. Finally, Goldman Sachs Group upgraded shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a research report on Friday, December 15th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $103.34.

In other AmerisourceBergen news, Director Richard W. Gochnauer sold 2,278 shares of AmerisourceBergen stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $101.13, for a total transaction of $230,374.14. Following the transaction, the director now directly owns 13,225 shares of the company’s stock, valued at $1,337,444.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Peyton R. Howell sold 17,800 shares of the business’s stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $89.70, for a total transaction of $1,596,660.00. The disclosure for this sale can be found here. Insiders have sold 177,609 shares of company stock worth $16,855,249 over the last ninety days. 27.30% of the stock is owned by insiders.

AmerisourceBergen Corp. (NYSE ABC) opened at $100.60 on Wednesday. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.50 and a current ratio of 0.95. AmerisourceBergen Corp. has a 52 week low of $71.90 and a 52 week high of $106.27. The company has a market cap of $22,100.00, a PE ratio of 57.49, a price-to-earnings-growth ratio of 1.48 and a beta of 1.03.

AmerisourceBergen (NYSE:ABC) last issued its earnings results on Tuesday, February 6th. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The company had revenue of $40.47 billion for the quarter, compared to the consensus estimate of $40.42 billion. During the same period in the previous year, the firm earned $1.36 earnings per share. AmerisourceBergen’s quarterly revenue was up 6.0% compared to the same quarter last year. equities analysts predict that AmerisourceBergen Corp. will post 6.58 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th were paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date was Friday, February 16th. AmerisourceBergen’s dividend payout ratio (DPR) is presently 86.86%.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.themarketsdaily.com/2018/03/14/amerisourcebergen-corp-abc-shares-bought-by-bluecrest-capital-management-ltd.html.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply